{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T23:26:58Z","timestamp":1692055618709},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1097\/inf.0000000000000241","type":"journal-article","created":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T08:16:55Z","timestamp":1388564215000},"page":"e173-e179","source":"Crossref","is-referenced-by-count":4,"title":["Steady-state Pharmacokinetics of Nevirapine Extended-release Tablets in HIV-1\u2013infected Children and Adolescents"],"prefix":"10.1097","volume":"33","author":[{"given":"Carlo","family":"Giaquinto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Anabwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Feiterna-Sperling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Nuttall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kgosidialwa","family":"Mompati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"K\u00f6nigs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico J.","family":"Mensa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Sabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan-Loi","family":"Yong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thuy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Quinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R3-17-20210202","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1128\/AAC.49.9.3966-3969.2005","article-title":"Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical setting.","volume":"49","author":"Gonzalez de Requena","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl 1","key":"R4-17-20210202","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/00126334-200309011-00002","article-title":"HIV resistance to nevirapine and other non-nucleoside reverse transcriptase inhibitors.","volume":"34","author":"Wainberg","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-17-20210202","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/QAD.0b013e32832ba8ec","article-title":"Antiretroviral medication adherence and the development of class-specific antiretroviral resistance.","volume":"23","author":"Gardner","year":"2009","journal-title":"AIDS"},{"key":"R6-17-20210202","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1651-2227.2003.tb00822.x","article-title":"Adherence to antiretroviral therapy and its determinants in children with human immunodeficiency virus infection: a multicentre, national study.","volume":"92","author":"Giacomet","year":"2003","journal-title":"Acta Paediatr"},{"key":"R7-17-20210202","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1542\/peds.109.4.e61","article-title":"Pediatric AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.","volume":"109","author":"Van Dyke","year":"2002","journal-title":"Pediatrics"},{"key":"R8-17-20210202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/DBP.0b013e3181856d22","article-title":"PACTG P1042S Team. Assessment of adherence to antiretroviral therapy in perinatally HIV-infected children and youth using self-report measures and pill count.","volume":"29","author":"Farley","year":"2008","journal-title":"J Dev Behav Pediatr"},{"key":"R9-17-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QAI.0b013e318183a996","article-title":"Association of antiretroviral and clinic adherence with orphan status among HIV-infected children in Western Kenya.","volume":"49","author":"Vreeman","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-17-20210202","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance.","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"R11-17-20210202","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication.","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"R12-17-20210202","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1086\/596482","article-title":"Better adherence with once-daily antiretroviral regimens: a meta-analysis.","volume":"48","author":"Parienti","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R13-17-20210202","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/aid.2006.22.232","article-title":"2NN Study Group. Pharmacokinetic parameters of nevirapine and efavirenz in relation to antiretroviral efficacy.","volume":"22","author":"Leth","year":"2006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R14-17-20210202","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(04)15997-7","article-title":"2NN Study team. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study.","volume":"363","author":"van Leth","year":"2004","journal-title":"Lancet"},{"key":"R16-17-20210202","first-page":"296","article-title":"2NN Study Group. Plasma HIV-1 RNA decline within the first two weeks of treatment is comparable for nevirapine, efavirenz, or both drugs combined and is not predictive of long-term virologic efficacy: A 2NN substudy.","volume":"38","author":"van Leth","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R17-17-20210202","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11904-009-0026-8","article-title":"Pediatric adherence to HIV antiretroviral therapy.","volume":"6","author":"Haberer","year":"2009","journal-title":"Curr HIVAIDS Rep"},{"key":"R19-17-20210202","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3851\/IMP1803","article-title":"Efficacy and safety of nevirapine extended-release once daily versus nevirapine immediate-release twice-daily in treatment-naive HIV-1-infected patients.","volume":"16","author":"Gathe","year":"2011","journal-title":"Antivir Ther"},{"key":"R20-17-20210202","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jchromb.2007.06.007","article-title":"Quantitation of five nevirapine oxidative metabolites in human plasma using liquid chromatography-tandem mass spectrometry.","volume":"856","author":"Rowland","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:02:45Z","timestamp":1620954165000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201407000-00017"}},"subtitle":["An Open-label, Multiple-dose, Cross-over Study"],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000241","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}